Within the study group, 65 patients (63%) had primary tumours with high TS expression (⩾25% of tumor cells positive), and 38 patients (37%) demonstrated low TS expression (<25% of tumour cells positive or no staining). The gene discussed is TYMS; the disease is neoplasm.